PharmacoEconomics

Transparency in Economic Evaluations
pp. 967-969(3)
Author: Hill, Suzanne

Measuring Health-Related Quality of Life in Older Patient Populations: A Review of Current Approaches
pp. 971-993(23)
Authors: Hickey, Anne; Barker, Maja; McGee, Hannah; O’Boyle, Ciaran

Pharmacological Management of Overactive Bladder: A Systematic and Critical Review of Published Economic Evaluations
pp. 995-1006(12)
Authors: Getsios, Denis; El-Hadi, Wissam; Caro, Ingrid; Caro, J. Jaime

The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach
pp. 1007-1020(14)
Author: Hertzman, Peter

Using Policy Simulation to Predict Drug Plan Expenditure when Planning Reimbursement Changes
pp. 1021-1030(10)
Authors: Dormuth, Colin R.; Burnett, Sean; Schneeweiss, Sebastian

Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease
pp. 1031-1041(11)
Authors: Hughes, Dyfrig A.; Bodger, Keith; Bytzer, Peter; Dirk de Herdt,; Dubois, Dominique

Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon--2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1
pp. 1043-1055(13)
Authors: Buti, Maria; Casado, Miguel A.; Fosbrook, Leslie; Esteban, Rafael

Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure
pp. 1057-1072(16)
Authors: Croom, Katherine F.; Plosker, Greg L.